Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic testing for Alzheimer's disease.

P K Panegyres1, J Goldblatt, I Walpole

  • 1Neurosciences Unit, Health Department of Western Australia, Perth, WA. peter.panegyres@rph.health.wa.gov.au

The Medical Journal of Australia
|June 9, 2000
PubMed
Summary

Genetic testing can aid Alzheimer's disease (AD) diagnosis, particularly for early-onset familial cases by identifying specific gene mutations. However, apolipoprotein E (APOE) genotyping has limited diagnostic value for sporadic AD and should not be used alone or in asymptomatic individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiomic analysis identifies glutaminolysis-dependent metabolic enhancement of immune memory utilised for vaccine development.

Nature communications·2026
Same author

Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The Lunar Environment Heliophysics X-ray Imager (LEXI) Mission.

Space science reviews·2024
Same author

Anti-neutrophil cytoplasmic antibody associated vasculitis of the brain and oral cavity: a case report.

Oxford medical case reports·2023
Same author

Correction: An online parenting intervention to prevent affective disorders in high-risk adolescents: the PIPA trial protocol.

Trials·2022
Same author

An online parenting intervention to prevent affective disorders in high-risk adolescents: the PIPA trial protocol.

Trials·2022

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Genetic factors significantly influence Alzheimer's disease (AD) development.
  • Rare mutations in specific genes cause familial AD, while apolipoprotein E (APOE) gene variants are risk factors for late-onset sporadic AD.

Purpose of the Study:

  • To explore the utility of genetic information in diagnosing Alzheimer's disease.
  • To provide guidance on the appropriate use of genetic testing in AD diagnosis and risk assessment.

Main Methods:

  • Review of current understanding of AD genetics.
  • Analysis of the potential diagnostic and predictive value of gene mutations (presenilin, amyloid precursor protein) and APOE genotyping.
  • Consideration of ethical guidelines for genetic testing.

Related Experiment Videos

Main Results:

  • Testing for presenilin and amyloid precursor protein gene mutations is recommended for patients with a family history of early-onset dementia and suggestive clinical features, with proper counseling.
  • APOE genotyping shows low sensitivity and specificity, offering limited predictive value for individual patients and should not be used as a sole diagnostic test.
  • APOE testing is not recommended for asymptomatic individuals outside of research settings.

Conclusions:

  • Genetic testing can be a valuable tool in specific AD diagnostic scenarios, particularly for familial early-onset AD.
  • APOE genotyping's role in routine AD diagnosis is currently limited due to insufficient predictive power.
  • Strict adherence to guidelines and comprehensive counseling are essential for all genetic testing related to Alzheimer's disease.